galactosamine has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gove, CD; Hughes, RD; Kmiec, Z; Moore, KP; Nouri-Aria, KT; Sheron, N; Williams, R | 1 |
| Iwai, M; Shimazu, T; Yamauchi, T | 1 |
2 other study(ies) available for galactosamine and thromboxane a2
| Article | Year |
|---|---|
Effect of supernatants from Kupffer cells stimulated with galactosamine and endotoxin on the function of isolated rat hepatocytes.
Topics: Animals; Cells, Cultured; Endotoxins; Epoprostenol; Escherichia coli; Galactosamine; Kupffer Cells; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Male; Rats; Rats, Wistar; Thromboxane A2; Tumor Necrosis Factor-alpha | 1993 |
Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with D-galactosamine.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Galactosamine; Hemodynamics; L-Lactate Dehydrogenase; Liver; Liver Circulation; Liver Diseases; Male; Perfusion; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1998 |